AgingResearch.NewsJoin free

IL-4-treated hematopoietic stem and progenitor cell transplantation

IL-4-treated hematopoietic stem and progenitor cell transplantation has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 30, 2026: “Immune signal restored B and T cell production in aged mice”.

Intervention

1 paper studies it1 findingUpdated

See all 1

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Howard Hughes Medical Institute and 1 more
  • Animals1

What did studies of IL-4-treated hematopoietic stem and progenitor cell transplantation find?

1

Studies of IL-4-treated hematopoietic stem and progenitor cell transplantation measured 1 outcome; the most studied are physical function (1 study).

Physical function

upin mice1

1 study

  1. IL-4-treated hematopoietic stem and progenitor cell transplantation improves physical function in mice (transplantation of IL-4-treated HSPCs).

    “these rejuvenating effects were recapitulated by transplantation of IL-4-treated HSPCs.”

    Animalstransplantation of IL-4-treated HSPCs

    Immune signal restored B and T cell production in aged mice

    Immunity

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
Immunity

Immune signal restored B and T cell production in aged mice

Experiments in 18-month-old male mice tested interleukin 4; two four-week courses also improved immune, metabolic, physical and cognitive functions.Experiments in 18-month-old male mice tested interleukin 4; two four-week courses also improved immune, metabolic, physical and cognitive functions.

Mouse studyBlood and immune system
Paper

Related